We're Pausing Asimov Press

18 hours ago

Asimov Press is going on hiatus with operations pausing in April, though all articles will remain freely accessible online.
Started in June 2023, the press grew from 7,000 to about 42,000 subscribers and published 149 original articles, reaching half a million readers monthly.
Key roles included editors Niko and Xander Balwit, copy editor Devon Balwit, art director Ella Watkins-Dulaney, and contributors like Ulkar Aghayeva.
Notable articles covered topics such as the penicillin myth, clinical trials, mitochondria, and artemisinin, with some influencing policy and funding discussions.
The press successfully published and sold out two anthologies, including a book available in both print and DNA, and donated profits to charity.
The hiatus is due to new projects calling away the founders, not funding issues, and the press has been supported by Asimov, Astera Institute, and Stripe.
The experience emphasized the value of deep research and connecting with experts, reinforcing a commitment to writing and editing in the future.

Hasty Briefsbeta